Loading…

Browse All Grants

99,167 grants found

Filters
Reset

Showing 4,5214,540 of 99,167 grants

Completed NON-SBIR/STTR RPGS
IMAAP: Development and evaluation of an Interactive Mobile Asthma Action Plan
NATIONAL INSTITUTE OF NURSING RESEARCH Cincinnati Childrens Hosp Med Ctr United States 2024 – 2026

Project Summary This project will include the development and evaluation of IMAAP, an Interactive Mobile Asthma Action Plan to support asthma self-management and adherence to ‘as n...

$4.41M
USD
Completed NON-SBIR/STTR RPGS
Targeting EBV's Deubiquitinating Activity for Therapy
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... New York Medical College United States 2024 – 2026

Project Summary/Abstract Epstein-Barr Virus (EBV), a human tumor virus, is the causative agent of mononucleosis and immunoblastic lymphomas. EBV is strongly associated with Burkitt...

$2.48M
USD
Completed NON-SBIR/STTR RPGS
Antigen specificity of plasma cells in Hidradenitis suppurativa skin lesions
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Emory University United States 2024 – 2026

Project Summary Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis that causes recurrent scarring abscesses and tunnels in the groin, axillae, and perineum. It affe...

$2.64M
USD
Active NON-SBIR/STTR RPGS
Multivalent Small Circular mRNA Vaccines for Melanoma Combination Immunotherapy
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

Abstract Melanoma is the most serious type of skin cancer. Although immune checkpoint blockade (ICB) therapy has benefited many melanoma patients, most patients do not respond to c...

$5.77M
USD
Active NON-SBIR/STTR RPGS
Macropinocytosis Inhibition as a Glutamine Mimetic Sensitization Strategy in Pancreatic Cancer
NATIONAL CANCER INSTITUTE Sanford Burnham Prebys Medical Discovery... United States 2024 – 2029

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) cells depend on glutamine to meet their unique metabolic needs. Glutamine fuels a wide array of biosynthetic pathways; howev...

$5.61M
USD
Completed NON-SBIR/STTR RPGS
Defining the neovaginal microbiome after gender affirming vaginoplasty
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Case Western Reserve University United States 2024 – 2026

Project Summary It is estimated that up to 0.6% of the US population is transgender, which describes someone whose gender identity is incompatible with their sex assigned at birth....

$2.42M
USD
Active NON-SBIR/STTR RPGS
Dissecting and Targeting MAST1 Signaling in chemoresistant Cancers
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

PROJECT SUMMARY Platinum drugs such as cisplatin serve as a mainstay of cancer therapy, but resistance limits their curative potential. Through a kinome-wide RNAi screen, we identi...

$4.34M
USD
Active NON-SBIR/STTR RPGS
Ceramides in Diastolic Heart Failure
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Utah United States 2024 – 2029

SUMMARY This proposal explores the hypothesis that very long chain ceramides serve as a causal mediator in the structural and functional changes which underlie diastolic heart fail...

$7.24M
USD
Active NON-SBIR/STTR RPGS
SCH: Improving Early Prediction and Decision-Making for Sepsis with Human-AI Collaboration
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Ohio State University United States 2024 – 2028

Early prediction and timely decision-making of acute diseases are critical to enabling early intervention and improving clinical outcomes (for example, a sepsis patient may benefit...

$3M
USD
Active NON-SBIR/STTR RPGS
The Impact of Natural Disasters on Child Health
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... University of Southern California United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Climate change is increasing the frequency, intensity, and human toll of extreme weather events such as floods and hurricanes. Children living in low and m...

$6.28M
USD
Active NON-SBIR/STTR RPGS
Coordinating and Data Sharing Center - R&D of Vaccines and Antibodies for Pandemic Preparedness (ReVAMPP)
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Research Triangle Institute United States 2024 – 2027

0BPROJECT SUMMARY/ABSTRACT The global pandemic caused by SARS-CoV-2 highlighted the continual threat of emerging and re-emerging pandemic-potential pathogens and the critical value...

$79.95M
USD
Active NON-SBIR/STTR RPGS
Development of a Universal Vaccine Against Leptospirosis
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of Connecticut Storrs United States 2024 – 2029

PROJECT SUMMARY Leptospirosis, an emerging infectious disease, is a leading zoonotic cause of morbidity and mortality worldwide, conveying the greatest burden to subsistence farmer...

$8.23M
USD
Active NON-SBIR/STTR RPGS
Evaluation of the AMPK-BACH1-NRF2 Axis as a Therapeutic Target for Inherited DCM
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Stanford University United States 2024 – 2028

Dilated cardiomyopathy (DCM)-associated heart failure is a leading cause of death. About a third of all DCM is caused by variants in genes controlling heart muscle structure and/or...

$6.02M
USD
Completed NON-SBIR/STTR RPGS
Characterizing the early childhood neurodevelopmental impact of infants exposed to maternal SARS-CoV-2 infection during pregnancy
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Lurie Children'S Hospital of Chicago United States 2024 – 2026

Project Abstract Pregnant people are uniquely susceptible to SARS-CoV-2 infection, with risks of severe maternal COVID-19 illness and obstetric complications. However, far less is...

$832K
USD
Active NON-SBIR/STTR RPGS
Identifying and modulating pathologic T cells that govern oral mucosal immune related adverse events from immune checkpoint blockade
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEAR... Oregon Health & Science University United States 2024 – 2029

Immune related adverse events (irAEs) secondary to checkpoint blockade inhibition (CBI) or other immune modulatory therapy for cancer, including head and neck cancers, are a signif...

$7.05M
USD
Completed NON-SBIR/STTR RPGS
S1PR1-targeted PET imaging to predict and monitor response to HER2-targeting antibody-drug conjugates
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT – In patients with gastric cancers who are clinically classified as HER2- positive, antibody-drug conjugates (ADC) prolong progression-free and overall sur...

$4M
USD
Active NON-SBIR/STTR RPGS
Autonomic Reactivity to Restore a Dysregulated Brain-Gut Axis via Targeted Therapy
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Medical College of Wisconsin United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Disorders of gut-brain interaction (DGBI) affect up to 25% of U.S. children. Patients often suffer from disabling, multisystem comorbidities that suggest a...

$4.31M
USD
Completed NON-SBIR/STTR RPGS
Improving Traumatic Stress in Black Women Experiencing Homelessness: Evaluation of a Stakeholder Engaged Intervention
NATIONAL INSTITUTE OF NURSING RESEARCH Rush University Medical Center United States 2024 – 2024

PROJECT SUMMARY/ABSTRACT Homelessness and associated traumas disproportionately impact Black women. While women experiencing homelessness (WEH) universally face traumatic stress, B...

$6.34M
USD
Completed NON-SBIR/STTR RPGS
In vitro approaches to study human cerebellar development
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... Seattle Children'S Hospital United States 2024 – 2026

PROJECT SUMMARY The human cerebellum despite its small size relative to the cerebral cortex, contains nearly 80% of all neurons in the brain. While it is classically associated wit...

$4.79M
USD
Completed NON-SBIR/STTR RPGS
Brainstem microRNA dysregulation in the pathogenesis of sudden infant death syndrome (SIDS)
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... Boston Children'S Hospital United States 2024 – 2026

PROJECT SUMMARY Despite fewer deaths as a result of the Safe Sleep campaign, the Sudden Infant Death Syndrome (SIDS) remains the leading cause of post-neonatal infant mortality in...

$2.67M
USD